Erickson R P
Lymphology. 2014 Dec;47(4):196-7.
The availability of massively parallel DNA sequencers has brought the cost of sequencing genes to affordable levels but the cost of analyzing the huge amount of data has not decreased to the same extent. Thus, only analyzing the sequences of the genes relevant to the patient's condition makes the cost manageable. A panel of genes relevant to lymphedematous conditions is described.
大规模并行DNA测序仪的出现使基因测序成本降至可承受水平，但分析海量数据的成本并未同等程度下降。因此，仅分析与患者病情相关的基因序列可使成本可控。本文描述了一组与淋巴水肿相关的基因。
